摘要: Abstract The goal in administering chemotherapeutics is to develop the ability predict outcome of therapy terms response and toxicity. Technology has been developed allow tumor profiling with measurement protein expression gene levels markers even genetic polymorphisms that may particular chemotherapeutics. for which have shown include fluoropyrimidines platinums. next step clinical trials will prospectively assess benefits a patient’s tumor, should translate into an improvement